Director Christina Jenkins resigns from Predictive Oncology board, effective Aug 31, 2022

Axe Compute Inc.

Dr. Christina Jenkins notified resignation as director, effective August 31, 2022, to focus on other business interests.
She confirmed resignation not due to any disagreement with company's operations, policies, or practices.
No replacement was announced; the board size and composition implications are not disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christina Jenkins

director

AGPU · Axe Compute Inc.

Effective: 2022-08-31
Filed: May 23, 2022, 7:59 PM ET

On May 18, 2022, Christina Jenkins, M.D. notified Predictive Oncology® Inc. (the “Company”) that she intends to resign as a director of the Company, effective August 31, 2022, in order to devote more time to her other business interests.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christina Jenkins resigned as director at Axe Compute Inc..

Action: resigned
Role: director

Exact text from the filing

On May 18, 2022, Christina Jenkins, M.D. notified Predictive Oncology® Inc. (the “Company”) that she intends to resign as a director of the Company, effective August 31, 2022, in order to devote more time to her other business interests.

View on SEC.gov

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-22-003878

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.